Michael J. Purcell Insider Profile
11 Followers
Michael J. Purcell, Director at Hepion Pharmaceuticals, holds 3.25M shares in Hepion Pharmaceuticals (Ticker: HEPA), holds 98.56K shares in International Money Express (Ticker: IMXI), holds 139.32K shares in Tabula Rasa HealthCare (Ticker: TRHC). Most recently, Michael J. Purcell Bought ― shares of Hepion Pharmaceuticals on Aug 12, 2026 for an estimated value of $100.00K.
Michael J. Purcell Hepion Pharmaceuticals (HEPA)Director
Hepion Pharmaceuticals (HEPA)
Director
Ranked #34,592 out of 109,030 Corporate Insiders
Profitable Transactions
4 out of 5 Profitable Transactions
Average Return
+5.60%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Michael J. Purcell holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:Nov 22, 2021 - Nov 22, 2022
Return:+37.40%
The most profitable trade made by Michael J. Purcell
Michael J. Purcell's Trading History
Hepion Pharmaceuticals
Aug 12, 2026
Director
Informative Buy
100.00K
$256.75K
Carrier & Technology Solutions LLC
Jan 25, 2017
―
Uninformative Buy
―
―
Tabula Rasa HealthCare
Jun 13, 2023
―
Uninformative Buy
―
$1.46M
International Money Express
Jul 20, 2026
Director
Uninformative Buy
150.00K
$1.40M
List of latest transactions for each holding click on a transaction to see Michael J. Purcell's performance on stock
You May Also Like
Michael J. Purcell insider profile FAQ
What is the percentage of profitable transactions made by Michael J. Purcell?
The percentage of profitable transactions made by Michael J. Purcell is 80%.
What is the average return per transaction made by Michael J. Purcell?
The average return per transaction made by Michael J. Purcell is 5.60%.
What stocks does Michael J. Purcell hold?
Michael J. Purcell holds: HEPA, PNTPQ, TRHC, IMXI stocks.
What was Michael J. Purcell’s latest transaction?
Michael J. Purcell latest transaction was an Informative Buy of $100.00K.
What was Michael J. Purcell's most profitable transaction?
Michael J. Purcell’s most profitable transaction was an Informative Buy of IMXI stock on November 22, 2021. The return on the trade was 37.40%.
What is Michael J. Purcell's role in Hepion Pharmaceuticals?
Michael J. Purcell's role in Hepion Pharmaceuticals is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.